ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1760

Fungal Composition of the Nasal Mucosa in Patients with Granulomatosis with Polyangiitis

Rennie L. Rhee1, Antoine G. Sreih1, Catherine E. Najem2, Peter C. Grayson3, Chunyu Zhao4, Kyle Bittinger4, Ronald Collman5 and Peter A. Merkel6, 1Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology, University of Pennsylvania, Philadelphia, PA, 3National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD, 4Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, PA, 6Division of Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Disease Activity, Wegener's granulomatosis and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Vasculitis – ANCA-Associated Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

While prior studies have demonstrated that granulomatosis with polyangiitis (GPA; Wegener’s) is associated with an altered composition of nasal bacteria and that use of an antibiotic may reduce the risk of relapse, no studies have evaluated the role of nasal fungi in GPA. It has been suggested that fungi may stabilize bacterial communities and interact with the immune system. Using deep sequencing methods, this study evaluated the composition of nasal fungi in GPA compared to healthy controls and examined interactions between nasal fungi and bacteria.

Methods:

Fungal internal transcribed spacer (ITS) and bacterial 16S rRNA gene sequencing were performed on DNA isolated from nasal swabs of 60 participants with GPA and 41 healthy controls. Main results of bacterial DNA sequencing were previously reported. Total fungal content was determined by PicoGreen-quantification. Using Wilcoxon rank sum test and generalized linear models, the abundance of total fungi and the most abundant fungal taxa (Malasseziales) were compared in GPA vs controls as well as within GPA subgroups: disease activity according to the BVAS/WG, ANCA type, sinonasal damage, and use of medications (immunosuppressants and antibiotics). Correlation in the abundance of fungi and bacteria were assessed using Spearman’s correlation coefficient.

Results:

Malasseziales was the most abundant fungal taxa present followed by the genera Penicillium and Aspergillus. There was a non-significant trend towards lower abundance of total fungi in GPA vs controls (p = 0.06). When evaluating the most abundant taxa Malasseziales, we found a significantly lower abundance of Malasseziales in GPA vs controls (p = 0.04) and this difference was most pronounced in the group with active GPA which had a significantly lower abundance compared to GPA in remission (p = 0.04) and healthy controls (p = 0.01)(Figure 1). No associations were found among the other co-variates. There was significant positive correlation in the 5 most common bacterial species present in the samples and abundance of total fungi (Figure 2) as well as abundance of Malasseziales (data not shown).

Conclusion:

The abundance of Malasseziales is significantly lower in the nasal mucosa of GPA vs controls and is associated with disease activity in GPA. Co-variation in the abundance of fungi and several bacterial species suggests fungi and bacteria may interact in the nose. These results support the possibility that commensal fungal communities and their interactions with bacteria may be involved in disease pathogenesis of GPA.


Disclosure: R. L. Rhee, None; A. G. Sreih, None; C. E. Najem, None; P. C. Grayson, None; C. Zhao, None; K. Bittinger, None; R. Collman, None; P. A. Merkel, None.

To cite this abstract in AMA style:

Rhee RL, Sreih AG, Najem CE, Grayson PC, Zhao C, Bittinger K, Collman R, Merkel PA. Fungal Composition of the Nasal Mucosa in Patients with Granulomatosis with Polyangiitis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fungal-composition-of-the-nasal-mucosa-in-patients-with-granulomatosis-with-polyangiitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fungal-composition-of-the-nasal-mucosa-in-patients-with-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology